AZE Share Price Performance
€0
-18.06 (-100.00%)
Price €0
Fair Value€16.00
Share Pricen/a
Investor Optimism Abounds Azelis Group NV (EBR:AZE) But Growth Is Lacking
Nov 14
Azelis Group NV Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 13 Fair Values set on narratives written by author
AZE Community Narratives
AN
Fair Value €16 42.0% undervalued intrinsic discount
Specialty Chemicals Will Endure Market Headwinds With Gradual Relief
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value €24 61.4% undervalued intrinsic discount
Rising Demand For Specialty Chemicals Will Fuel Market Expansion
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value €17.39 46.7% undervalued intrinsic discount
Recovery Will Likely Emerge After Industry Pressures Ease In 2026
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
Recovery Will Likely Emerge After Industry Pressures Ease In 2026
Key Takeaways Strategic acquisitions and a strong M&A pipeline suggest future revenue growth and expanded net margins from realized synergies. Investments in digitalization and sustainability could drive operational efficiencies, improving net margins and earnings stability long-term.Read more
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
€17.39
46.7% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
3.85% p.a.
Profit Margin
4.48%
Future PE
26.09x
Share price in 2028
€22.73
Specialty Chemicals Will Endure Market Headwinds With Gradual Relief
Key Takeaways Reliance on end market recovery and successful acquisition integration introduces vulnerability to earnings growth, especially if life sciences momentum weakens or industrials underperform. Sustainability investments and ambitious ESG targets risk margin pressure, while higher working capital and limited order book visibility challenge cash flow and financial flexibility.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
€16
42.0% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
3.27% p.a.
Profit Margin
4.72%
Future PE
22.9x
Share price in 2028
€20.67
Rising Demand For Specialty Chemicals Will Fuel Market Expansion
Key Takeaways Market consensus underestimates Azelis' rapid rebound in high-margin segments and strong post-acquisition integration, likely leading to outperformance in revenue and profit growth. Azelis' expanding role in value-added services, digitalization, and sustainability uniquely positions it for lasting market share gains and elevated customer retention.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
€24
61.4% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
7.38% p.a.
Profit Margin
5.53%
Future PE
26.11x
Share price in 2028
€31
Recently Updated Narratives
AN
Recovery Will Likely Emerge After Industry Pressures Ease In 2026
Fair Value: €17.39 46.7% undervalued intrinsic discount
6 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Specialty Chemicals Will Endure Market Headwinds With Gradual Relief
Fair Value: €16 42.0% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Demand For Specialty Chemicals Will Fuel Market Expansion
Fair Value: €24 61.4% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Azelis Group NV Key Details
About AZE
- Founded
- 1996
- Employees
- 4321
- CEO
- WebsiteView website
Azelis Group NV engages in the distribution and sale of specialty chemicals and food ingredients. The company sells specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, flavours and fragrances, and agricultural environmental solutions; and industrial chemicals industry, such as CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.
